Revenue and Profit - The company's revenue for Q1 2025 was CNY 385,550,493.62, representing a 57.42% increase compared to CNY 244,924,392.62 in the same period last year[5] - Net profit attributable to shareholders decreased by 26.66% to CNY 15,702,915.91 from CNY 21,411,400.56 year-on-year[5] - Total operating revenue for the current period reached ¥385,550,493.62, a significant increase of 57.3% compared to ¥244,924,392.62 in the previous period[20] - Net profit for the current period was ¥15,702,915.91, a decrease of 26.7% from ¥21,411,400.56 in the previous period[21] - The company experienced a total comprehensive income of ¥15,701,528.20, down from ¥21,411,400.56 in the previous period[21] Cash Flow - The net cash flow from operating activities improved significantly, with a net outflow of CNY -2,643,482.84, a 93.98% increase compared to CNY -43,921,036.88 in the previous year[5] - Cash flow from operating activities showed a net outflow of ¥2,643,482.84, an improvement from a net outflow of ¥43,921,036.88 in the prior period[23] - Cash flow from investing activities generated a net inflow of ¥94,190,963.70, compared to a net outflow of ¥208,209,551.35 in the previous period[23] Assets and Liabilities - Total assets increased by 2.52% to CNY 2,430,901,186.06 from CNY 2,371,260,346.31 at the end of the previous year[5] - The company's total liabilities were CNY 684,218,373.28, compared to CNY 640,223,940.44 at the beginning of the period, marking an increase of about 6.9%[18] - Current assets totaled CNY 2,072,963,270.84, slightly up from CNY 2,027,411,674.04, indicating a growth of about 2.2%[17] - The total non-current assets amounted to CNY 357,937,915.22, up from CNY 343,848,672.27, reflecting a growth of approximately 4.1%[18] Cash and Equivalents - The cash and cash equivalents increased by 135.19%, amounting to a net increase of CNY 85,651,595.93 compared to a net decrease of CNY -243,392,303.05 in the previous year[9] - Cash and cash equivalents at the end of the period totaled ¥386,195,761.97, up from ¥118,768,918.30 at the end of the previous period[24] - Cash and cash equivalents increased to CNY 427,428,592.76 from CNY 310,546,366.47, representing a significant rise of approximately 37.6%[17] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 26,479[10] - The equity attributable to the parent company reached CNY 1,746,682,812.78, up from CNY 1,731,036,405.87, showing a growth of approximately 0.9%[19] Operating Costs and Expenses - The company experienced a 78.72% increase in operating costs, totaling CNY 350,214,583.05 compared to CNY 195,956,053.32 in the same period last year[9] - Total operating costs amounted to ¥370,932,761.05, up 67.0% from ¥222,307,235.73 in the prior period[20] - Research and development expenses decreased to ¥6,090,631.15 from ¥7,960,492.47, reflecting a reduction of 23.5%[20] Earnings Per Share - The company's basic earnings per share decreased by 25.00% to CNY 0.03 from CNY 0.04 year-on-year[5] - Basic and diluted earnings per share were both ¥0.03, down from ¥0.04 in the previous period[21] Investment Income - The company reported a 60.51% increase in investment income, reaching CNY 8,042,803.94 compared to CNY 5,010,661.23 in the same period last year[9] - The company reported an investment income of ¥8,042,803.94, an increase from ¥5,010,661.23 in the prior period[20]
华融化学(301256) - 2025 Q1 - 季度财报